JPRN-UMIN000023089已完成未知
chemotherapy for primary bone sarcoma over 41 except for Ewing sarcoma - chemotherapy for primary bone sarcoma over 41
Gifu Gfraduate University school of medicine0 个研究点目标入组 200 人开始时间: 2016年7月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 41years-old 至 70years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •<41 years old low grade malignancy
研究者
相似试验
已完成
1 期
chemotherapy for soft tissue sarcomasoft tissue sarcomaJPRN-UMIN000013056agoya City University Graduate School of Medical Sciences40
已完成
不适用
A European treatment protocol for bonesarcomain patients older than 40 years (EURO-B.O.S.S.)C40Malignant neoplasm of bone and articular cartilage of limbsDRKS00000942Klinikum Stuttgart135
Unknown
1 期
A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With OsteosarcomaOsteosarcomaNCT04316091Second Affiliated Hospital, School of Medicine, Zhejiang University60
招募中
2 期
Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of RelapseOsteosarcomaEwing SarcomaNCT04758000Istituto Ortopedico Rizzoli67
进行中(未招募)
1 期
Administration of Metformin as maintenance therapy in patients with osteosarcoma or Ewing's sarcomaOsteosarcoma and Ewing's SarcomaMedDRA version: 20.0Level: PTClassification code 10023676Term: Lactic acidosisSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.1Level: LLTClassification code 10000491Term: Acidosis lacticSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2020-002579-37-ITISTITUTO ORTOPEDICO RIZZOLI60
